Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27601600 | 0.95 | LMNA (0.69) | LMNATDP1CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL296159 | 0.90 | LMNA (0.76) | LMNATDP1CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL3677170 | 0.87 | LMNA (0.54) | LMNATDP1CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL3677167 | 0.87 | LMNA (0.54) | LMNATDP1CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL1150261 | 0.84 | LMNA (0.49) | LMNATDP1CYP1A2CYP2C19CYP2D6 | |
| SCHEMBL357783 | 0.84 | LMNA (0.49) | LMNATDP1CYP1A2CYP2C19CYP2D6 | |
| SCHEMBL1150263 | 0.84 | LMNA (0.49) | LMNATDP1CYP1A2CYP2C19CYP2D6 | |
| Chrysanthemic Acid, Ethyl Ester SCHEMBL3676624 | 0.83 | LMNA (1.00) | LMNATDP1CYP1A2CYP2C19CYP3A4 | |
| Chrysanthemic Acid, Ethyl Ester SCHEMBL294267 | 0.83 | LMNA (1.00) | LMNATDP1CYP1A2CYP2C19CYP3A4 | |
| Chrysanthemic Acid, Ethyl Ester SCHEMBL10712272 | 0.83 | LMNA (1.00) | LMNATDP1CYP1A2CYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4788323-A | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-29 | — | — | US | claimed |
| US-4659864-A | USING ALUMINUM BORMIDE AND A HYDROPEROXIDE | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1987-04-21 | — | — | US | claimed |
| CN-105685021-A | Insecticide mother liquor and application thereof | 中山榄菊日化实业有限公司 | 2016-06-22 | — | — | CN | disclosed |
| EP-1593674-B1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | SUMITOMO CHEMICAL CO (JP) | 2011-07-20 | — | — | EP | disclosed |
| US-7683215-B2 | Optically active bisoxazoline compounds, process for production of the same and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-23 | — | — | US | disclosed |
| US-7671213-B2 | Optically active bisoxazoline compounds, process for production of the same and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-02 | — | — | US | disclosed |
| US-20080076931-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ITAGAKI MAKOTO | 2008-03-27 | — | — | US | disclosed |
| US-20080076941-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ITAGAKI MAKOTO | 2008-03-27 | — | — | US | disclosed |
| EP-1463706-B1 | PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES | SUMITOMO CHEMICAL CO (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-7288674-B2 | Optically active bisoxazoline compounds, process for production of the same and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-30 | — | — | US | disclosed |
| US-7262320-B2 | Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-08-28 | — | — | US | disclosed |
| EP-0261824-A1 | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-03-30 | — | — | EP | disclosed |
| US-4723035-A | Method for racemization of chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-02-02 | — | — | US | disclosed |
| US-4659864-A | USING ALUMINUM BORMIDE AND A HYDROPEROXIDE | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1987-04-21 | — | — | US | disclosed |
| US-4644080-A | Method for racemization of chrysanthemic acid or its ester | SUMITOMO CHEMICAL CO., LTD. (JP) | 1987-02-17 | — | — | US | disclosed |
| EP-0062979-B1 | A METHOD OF EPIMERIZATION OF ALKYL CHRYSANTHEMATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-01-08 | — | — | EP | disclosed |
| EP-0165070-A2 | Method for racemization of chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-12-18 | — | — | EP | disclosed |
| EP-0155765-A1 | Method for racemization of chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-09-25 | — | — | EP | disclosed |
| US-4473703-A | TREATMENT WITH LEWIS ACID | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-09-25 | — | — | US | disclosed |
| EP-0062979-A1 | A method of epimerization of alkyl chrysanthemate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076941-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ACSL3, ADSL, SQLE | LMNA 2541/4885TDP1 4483/4885CYP1A2 25/4885 |
| US-20080076931-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ACSL3, ADSL, SQLE | LMNA 2541/4885TDP1 4483/4885CYP1A2 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.